Es gab 50 kürzliche Insider-Transaktionen für Keros Therapeutics, Inc. (KROS), darunter 23 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $17.44M und die gesamten Insider-Verkäufe auf $23.86M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Seehra Jasbir, Bienaime Jean Jacques, Newton Charles W.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — KROS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-02 |
Seehra Jasbir |
Chief Executive Officer |
Optionsausübung (Verkauf) |
55,000 |
$0.30 |
$16.5K |
197,444 |
| 2026-03-09 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
2,000 |
$11.21 |
$22.42K |
7,450 |
| 2026-03-09 |
Newton Charles W. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-03-09 |
Newton Charles W. |
Director |
RSU-Zuteilung |
13,215 |
- |
- |
13,215 |
| 2026-02-24 |
Regnante Keith |
Chief Financial Officer |
RSU-Zuteilung |
60,000 |
$15.52 |
$931.2K |
60,000 |
| 2026-02-24 |
Seehra Jasbir |
Chief Executive Officer |
RSU-Zuteilung |
100,000 |
$15.52 |
$1.55M |
100,000 |
| 2026-02-24 |
Cho Esther |
Chief Legal Officer |
RSU-Zuteilung |
80,000 |
$15.52 |
$1.24M |
80,000 |
| 2026-02-19 |
Seehra Jasbir |
Chief Executive Officer |
Informierter Verkauf |
7,015 |
$16.17 |
$113.43K |
385,708 |
| 2026-02-18 |
Regnante Keith |
Chief Financial Officer |
Informierter Verkauf |
4,739 |
$16.35 |
$77.48K |
39,261 |
| 2026-02-18 |
Lerner Lorena Raquel |
Chief Science Officer |
Informierter Verkauf |
3,873 |
$16.35 |
$63.32K |
31,127 |
| 2026-02-18 |
Cho Esther |
SVP, General Counsel |
Informierter Verkauf |
4,745 |
$16.35 |
$77.58K |
39,755 |
| 2026-01-07 |
Seehra Jasbir |
Chief Executive Officer |
RSU-Zuteilung |
62,500 |
$63.61 |
$3.98M |
62,500 |
| 2025-11-21 |
Orbimed Advisors Llc |
Director |
Aktienrückgabe |
74,465 |
$17.75 |
$1.32M |
45,057 |
| 2025-11-21 |
Gordon Carl L |
Director |
Aktienrückgabe |
74,465 |
$17.75 |
$1.32M |
45,057 |
| 2025-11-21 |
Knowles Julius |
Director |
Aktienrückgabe |
130,494 |
$17.75 |
$2.32M |
102,233 |
| 2025-10-15 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Informierter Verkauf |
743,358 |
$17.75 |
$13.19M |
- |
| 2025-10-15 |
Pontifax Management 4 G.p. (2015) Ltd. |
10 Percent Owner |
Informierter Verkauf |
155,262 |
$17.75 |
$2.76M |
- |
| 2025-09-03 |
Seehra Jasbir |
Chief Executive Officer |
RSU-Zuteilung |
90,500 |
- |
- |
392,723 |
| 2025-08-06 |
Lerner Lorena Raquel |
Chief Science Officer |
Unbekannt |
10,879 |
$43.99 |
$478.57K |
- |
| 2025-08-06 |
Cho Esther |
SVP, General Counsel |
Unbekannt |
50,000 |
$54.38 |
$2.72M |
- |
| 2025-06-20 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Optionsausübung (ITM) |
1 |
$60.00 |
$60.00 |
- |
| 2025-06-04 |
Bienaime Jean Jacques |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,450 |
| 2025-06-04 |
Gray Mary Ann |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Gordon Carl L |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Kariv Tomer |
10 Percent Owner |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Nussbaum Ran |
10 Percent Owner |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Seth Alpna |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Farzan Nima |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
5,250 |
| 2025-06-04 |
Knowles Julius |
Director |
RSU-Zuteilung |
5,250 |
- |
- |
6,441 |
| 2025-06-04 |
Kariv Tomer |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-06-04 |
Nussbaum Ran |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-05-16 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Option verfallen |
178 |
$10.00 |
$1.78K |
- |
| 2025-04-09 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Sonstige (Verkauf) |
74,333 |
- |
- |
50,000 |
| 2025-04-08 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Unbekannt |
949,333 |
- |
- |
- |
| 2025-04-04 |
Seehra Jasbir |
Chief Executive Officer |
Optionsausübung (Verkauf) |
49,367 |
$0.30 |
$14.81K |
252,444 |
| 2025-04-03 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Unbekannt |
17,800 |
$10.00 |
$178K |
- |
| 2025-02-18 |
Regnante Keith |
Chief Financial Officer |
RSU-Zuteilung |
44,000 |
- |
- |
44,000 |
| 2025-02-18 |
Rovaldi Christopher |
Chief Operating Officer |
RSU-Zuteilung |
60,000 |
- |
- |
60,000 |
| 2025-02-18 |
Chyung Yung H. |
Chief Medical Officer |
RSU-Zuteilung |
44,000 |
- |
- |
44,000 |
| 2024-11-08 |
Chyung Yung H. |
Chief Medical Officer |
RSU-Zuteilung |
110,000 |
$67.91 |
$7.47M |
110,000 |
| 2024-11-01 |
Chyung Yung H. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-02 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Unbekannt |
100 |
$60.00 |
$6K |
- |
| 2024-10-01 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Unbekannt |
200 |
$70.00 |
$14K |
- |
| 2024-08-13 |
Orbimed Advisors Llc |
Director |
Informierter Verkauf |
29,400 |
$44.01 |
$1.29M |
119,522 |
| 2024-08-13 |
Gordon Carl L |
Director |
Informierter Verkauf |
29,400 |
$44.01 |
$1.29M |
119,522 |
| 2024-06-03 |
Bienaime Jean Jacques |
Director |
RSU-Zuteilung |
17,600 |
$48.67 |
$856.59K |
17,600 |
| 2024-06-01 |
Bienaime Jean Jacques |
Director |
Veräußerung |
- |
- |
- |
200 |
| 2024-05-30 |
Gray Mary Ann |
Director |
RSU-Zuteilung |
10,000 |
$46.31 |
$463.1K |
10,000 |
| 2024-05-30 |
Gordon Carl L |
Director |
RSU-Zuteilung |
10,000 |
$46.31 |
$463.1K |
10,000 |
| 2024-05-30 |
Kariv Tomer |
10 Percent Owner |
RSU-Zuteilung |
10,000 |
$46.31 |
$463.1K |
10,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
